Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

ViiV Healthcare · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
bone-mineral-densityhiv-infections
hiv infections, tenofovir disoproxil fumarate, dolutegravir plus rilpivirine, two-drug regimen, bone mineral density, dual energy x-ray absorptiometry (dexa), human immunodeficiency virus-1, nucleoside reverse transcriptase inhibitor -sparing regimen, integrase inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892040
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.